PathogenDx and Zef Scientific Announce a Strategic Sales and Service Distribution Partnership for Microbial Testing in Canada

COTTSDALE, Ariz., July 2, 2019 /PRNewswire/ — PathogenDx, Inc., the Arizona based technology company which provides a DNA-based pathogen testing platform for the cannabis, hemp, agriculture and food safety industries announced today that they have entered into a strategic sales and service distribution partnership with Zef Scientific in Canada. This partnership has already closed its first account with a Canadian testing lab, and the... Read more

PathogenDx Launches the World’s First Quantitative Microarray Test for Cannabis

PDx-QUANT™ is a One-Stop Microbial Testing Solution SCOTTSDALE, Ariz., Oct. 12, 2018 /PRNewswire/ — PathogenDx, Inc., the innovative provider of DNA-based pathogen testing technology for the cannabis industry, announced today the release of the first quantitative microarray-based test for cannabis, PDx-Quant™, which can determine whether or not a sample exceeds a state or a federal regulatory agency’s specific standards.  This... Read more

DNA-Based Pathogen Testing Company PathogenDx Raises $3.4 Million in Convertible Note Round

TUCSON, Ariz., July 17, 2018 /PRNewswire/ — PathogenDx Corporation, the innovative provider of DNA-based pathogen testing technology for the cannabis, botanical, food and agriculture industries, announced today the successful completion of a $3.4 million capital raise, completing the company’s convertible note round. The PathogenDx capital raise was co-led by Altitude Investment Management and The Panther Opportunity Fund. Other key funders include CanopyVentures,... Read more